1. Home
  2. BDAI vs ALLR Comparison

BDAI vs ALLR Comparison

Compare BDAI & ALLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BDAI

Biddance AI Systems Inc. Class A Ordinary Share

N/A

Current Price

$1.93

Market Cap

22.7M

Sector

Technology

ML Signal

N/A

Logo Allarity Therapeutics Inc.

ALLR

Allarity Therapeutics Inc.

N/A

Current Price

$0.94

Market Cap

19.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BDAI
ALLR
Founded
1996
2004
Country
China
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
22.7M
19.3M
IPO Year
2018
2021

Fundamental Metrics

Financial Performance
Metric
BDAI
ALLR
Price
$1.93
$0.94
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
47.1K
★ 124.3K
Earning Date
10-23-2026
11-24-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $320,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.70
$0.77
52 Week High
$2.77
$1.84

Technical Indicators

Market Signals
Indicator
BDAI
ALLR
Relative Strength Index (RSI) 41.78 47.87
Support Level $1.84 $0.90
Resistance Level $2.29 $1.00
Average True Range (ATR) 0.34 0.09
MACD -0.03 0.01
Stochastic Oscillator 25.70 30.88

Price Performance

Historical Comparison
BDAI
ALLR

About BDAI Biddance AI Systems Inc. Class A Ordinary Share

Biddance AI Systems Inc, formerly Hitek Global Inc, is a provider of information technology consulting and solutions services. The company has two lines of business services to small and medium businesses, which consist of Anti-Counterfeiting Tax Control System tax devices, including Golden Tax Disk and printers, ACTCS services, and IT services; and services to large businesses, which include hardware sales and software sales. It generates revenues from Hardware and equipment sales, Tax services, and Software sales.

About ALLR Allarity Therapeutics Inc.

Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States. It is focused on the clinical development of its lead program: Stenoparib, which is being co-developed with a drug specific DRP companion diagnostic.

Share on Social Networks: